The Ethics of Switch/Simplify in Antiretroviral Trials: Non-Inferior or Just Inferior?

Andrew Carr; Jennifer Hoy; Anton Pozniak

doi:10.1371/journal.pmed.1001240

Loading metrics

Open Access

Essays are opinion pieces on a topic of broad interest to a general medical audience.

See all article types »

The Ethics of Switch/Simplify in Antiretroviral Trials: Non-Inferior or Just Inferior?

Andrew Carr ,

* E-mail: acarr@stvincents.com.au

Affiliations Clinical Research Program, Centre for Applied Medical Research, St Vincent's Hospital, Sydney, Australia, HIV/Immunology/Infectious Diseases Unit, St Vincent's Hospital, Sydney, Australia
⨯
Jennifer Hoy,

Affiliations Infectious Diseases Unit, Alfred Hospital, Melbourne, Australia, Department of Infectious Diseases, Faculty of Medicine, Nursing and Health Sciences, Monash University, Melbourne, Australia
⨯
Anton Pozniak

Affiliation Chelsea and Westminster Hospital, London, United Kingdom
⨯

The Ethics of Switch/Simplify in Antiretroviral Trials: Non-Inferior or Just Inferior?

Andrew Carr,
Jennifer Hoy,
Anton Pozniak

Published: July 17, 2012
https://doi.org/10.1371/journal.pmed.1001240

Reader Comments

Post a new comment on this article

Same argument was raised in 2010 & 2011

Posted by hhw233 on 01 Aug 2012 at 10:49 GMT

Dear Authors,

Thank you very much for the nicely written informative article which complies with our argument raised in our published articles in 2010 & 2011:

Alameri, M., Epstein, M. & Johnston, A. 2010. Generic and therapeutic substitutions: are they always ethical in their own terms? Pharm World Sci, 32, 691-5.

Al Ameri, M., Epstein, M. & Johnston, A. 2011. Generic and therapeutic substitution: a response to our critic. Int J Clin Pharm, 33, 881-881.

Best Regards,

Mubarak N. Al Ameri BPharm(Hons) MSc
Clinical Pharmacology
Barts and The London
Charterhouse Square
London, EC1M 6BQ, UK

No competing interests declared.

Subject Areas
?

For more information about PLOS Subject Areas, click here.
We want your feedback. Do these Subject Areas make sense for this article? Click the target next to the incorrect Subject Area and let us know. Thanks for your help!

Antiretroviral therapy
Is the Subject Area "Antiretroviral therapy" applicable to this article?

Thanks for your feedback.
Medical risk factors
Is the Subject Area "Medical risk factors" applicable to this article?

Thanks for your feedback.
Toxicity
Is the Subject Area "Toxicity" applicable to this article?

Thanks for your feedback.
HIV
Is the Subject Area "HIV" applicable to this article?

Thanks for your feedback.
Drug research and development
Is the Subject Area "Drug research and development" applicable to this article?

Thanks for your feedback.
Cardiovascular disease risk
Is the Subject Area "Cardiovascular disease risk" applicable to this article?

Thanks for your feedback.
Quality of life
Is the Subject Area "Quality of life" applicable to this article?

Thanks for your feedback.
HIV prevention pills
Is the Subject Area "HIV prevention pills" applicable to this article?

Thanks for your feedback.

The Ethics of Switch/Simplify in Antiretroviral Trials: Non-Inferior or Just Inferior?

The Ethics of Switch/Simplify in Antiretroviral Trials: Non-Inferior or Just Inferior?

Reader Comments

Post Your Discussion Comment

Why should this posting be reviewed?

Thank You!

Same argument was raised in 2010 & 2011

Posted by hhw233 on 01 Aug 2012 at 10:49 GMT